Cargando…

Topical Diacerein Decreases Skin and Splenic CD11c(+) Dendritic Cells in Psoriasis

Psoriasis is an inflammatory skin disease characterized by increased neo-vascularization, keratinocyte hyperproliferation, a pro-inflammatory cytokine milieu and immune cell infiltration. Diacerein is an anti-inflammatory drug, modulating immune cell functions, including expression and production of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunner, Susanne M., Ramspacher, Andrea, Rieser, Caroline, Leitner, Julia, Heil, Hannah, Ablinger, Michael, Tevini, Julia, Wimmer, Monika, Koller, Andreas, Piñón Hofbauer, Josefina, Felder, Thomas K., Bauer, Johann W., Kofler, Barbara, Lang, Roland, Wally, Verena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001455/ https://www.ncbi.nlm.nih.gov/pubmed/36901755 http://dx.doi.org/10.3390/ijms24054324

Ejemplares similares

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex
por: Ablinger, Michael, et al.
Publicado: (2018)

Transcriptome-Guided Drug Repurposing for Aggressive SCCs
por: Zauner, Roland, et al.
Publicado: (2022)

Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study
por: Wally, Verena, et al.
Publicado: (2013)

Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases
por: Kocher, Thomas, et al.
Publicado: (2017)

Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC
por: Zauner, Roland, et al.
Publicado: (2023)

5′RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa
por: Mayr, Elisabeth, et al.
Publicado: (2022)

RNA Trans-Splicing Modulation via Antisense Molecule Interference
por: Liemberger, Bernadette, et al.
Publicado: (2018)

Epigenetic and metabolic regulation of epidermal homeostasis
por: Wagner, Roland N., et al.
Publicado: (2021)

COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents
por: Liemberger, Bernadette, et al.
Publicado: (2023)

A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas
por: Wimmer, Monika, et al.
Publicado: (2020)

Influence of the regulatory peptide galanin on cytokine expression in human monocytes
por: Ramspacher, Andrea, et al.
Publicado: (2019)

A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa
por: Zwicklhuber, Janine, et al.
Publicado: (2023)

COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa
por: Petković, Igor, et al.
Publicado: (2022)

Galanin is a potent modulator of cytokine and chemokine expression in human macrophages
por: Koller, Andreas, et al.
Publicado: (2019)

Can we be SMaRT-er in our approach to cancer therapy?
por: Gruber, Christina, et al.
Publicado: (2015)

Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa
por: Welponer, Tobias, et al.
Publicado: (2021)

Ion-pair compounds of diacerein for enhancing skin permeability in vitro: the compatibility–permeability relationship of counter ion and diacerein
por: Liang, Yan, et al.
Publicado: (2022)

Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa
por: Ablinger, Michael, et al.
Publicado: (2021)

Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer
por: Woess, Katharina, et al.
Publicado: (2022)

Diacerein treatment prevents colitis-associated cancer in mice
por: Paulino, Daiane S M, et al.
Publicado: (2020)

An Update of Anthraquinone Derivatives Emodin, Diacerein, and Catenarin in Diabetes
por: Martorell, Miquel, et al.
Publicado: (2021)

Friend or Foe: Lipid Droplets as Organelles for Protein and Lipid Storage in Cellular Stress Response, Aging and Disease
por: Geltinger, Florian, et al.
Publicado: (2020)

Visible Spectrophotometric Estimation of Diacerein in Bulk and Pharmaceutical Dosage Forms
por: Sivakumar, R, et al.
Publicado: (2010)

Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats
por: Refaie, Marwa M. M., et al.
Publicado: (2016)

In vitro antibiofilm and bacteriostatic activity of diacerein against Enterococcus faecalis
por: Fu, Chunyan, et al.
Publicado: (2023)

Considerations for a Successful RNA Trans-splicing Repair of Genetic Disorders
por: Koller, Ulrich, et al.
Publicado: (2014)

Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
por: Bischof, Johannes, et al.
Publicado: (2022)

The transfer of specific mitochondrial lipids and proteins to lipid droplets contributes to proteostasis upon stress and aging in the eukaryotic model system Saccharomyces cerevisiae
por: Geltinger, Florian, et al.
Publicado: (2019)

Diacerein protects against iodoacetate-induced osteoarthritis in the femorotibial joints of rats
por: Jain, Achint, et al.
Publicado: (2015)

Diacerein: A potential therapeutic drug for the management of experimental periodontitis in rats
por: Zaki, Basma Mostafa, et al.
Publicado: (2015)

Diacerein: A potential multi-target therapeutic drug for COVID-19
por: de Oliveira, Pedro Gonçalves, et al.
Publicado: (2020)

Reposition of the anti-inflammatory drug diacerein in an in-vivo colorectal cancer model
por: Abdel-Latif, Raghda T., et al.
Publicado: (2022)

Exploration of diacerein as a neuroprotective adjuvant to Adenium obesum: An in-vivo study
por: Sharma, Neeraj Kumar, et al.
Publicado: (2023)

Atorvastatin and diacerein reduce insulin resistance and increase disease tolerance in rats with sepsis
por: da Silva, K. L. C., et al.
Publicado: (2018)

Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein
por: Eltobshi, Amal Ahmed, et al.
Publicado: (2018)

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia
por: Brachtl, Gabriele, et al.
Publicado: (2013)

Profiling trial burden and patients’ attitudes to improve clinical research in epidermolysis bullosa
por: Prodinger, Christine, et al.
Publicado: (2020)

A Stability-Indicating High Performance Liquid Chromatographic Method for the Determination of Diacerein in Capsules
por: Rao, Janhavi, et al.
Publicado: (2009)

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
por: Pavelka, Karel, et al.
Publicado: (2016)

Effects of diacerein on cartilage and subchondral bone in early stages of osteoarthritis in a rabbit model
por: Permuy, María, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ilee0e8md1n6qkv41634abn82s